NeueHealth Inc Cash Flow Conversion Efficiency
NeueHealth Inc cash flow conversion efficiency. Based on the latest financial reports, NeueHealth Inc (NEUE) has a cash flow conversion efficiency ratio of 0.007x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.83 Million) by net assets ($-393.06 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of NeueHealth Inc (2019–2024)
Cash flow conversion efficiency of NeueHealth Inc from 2019 to 2024. This chart illustrates how NeueHealth Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NEUE live share price for real-time trading data and today's change.
NeueHealth Inc Cash Flow Conversion Ratio Explained
NeueHealth Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
NeueHealth Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NeueHealth Inc ranked by their cash flow conversion efficiency. Also see NeueHealth Inc market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Haulotte Group SA
PA:PIG
|
0.029x |
|
Tenax Therapeutics Inc
NASDAQ:TENX
|
-0.125x |
|
2S Metal Public Company Limited
BK:2S
|
0.003x |
|
Nickel 28 Capital Corp
V:NKL
|
0.002x |
|
Kingstate Electronics
TWO:3206
|
0.095x |
|
Chin Yang Ind
KO:003780
|
0.034x |
|
Research Solutions Inc
NASDAQ:RSSS
|
0.053x |
|
Guillemot Corporation S.A.
PA:GUI
|
-0.006x |
Annual Cash Flow Conversion Efficiency for NeueHealth Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of NeueHealth Inc from 2019 to 2024. Review how much free cash does NeueHealth Inc generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-386.11 Million | $-123.22 Million | 0.319x | -97.02% |
| 2023-12-31 | $-254.62 Million | $-2.73 Billion | 10.708x | +4191.67% |
| 2022-12-31 | $939.68 Million | $234.47 Million | 0.250x | +287.24% |
| 2021-12-31 | $1.27 Billion | $82.06 Million | 0.064x | -47.76% |
| 2020-12-31 | $-464.07 Million | $-57.24 Million | 0.123x | +1014.56% |
| 2019-12-31 | $608.62 Million | $-8.21 Million | -0.013x | -- |
About NeueHealth Inc
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates in two segments, NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health and Premie… Read more